Glucagon-Producing Cell Expansion in Wistar Rats. Changes to Islet Architecture After Sleeve Gastrectomy

Obes Surg. 2021 May;31(5):2241-2249. doi: 10.1007/s11695-021-05264-6. Epub 2021 Feb 22.

Abstract

Purpose: Many studies about bariatric surgery have analyzed the effect of sleeve gastrectomy (SG) on glucose improvement, beta-cell mass, and islet size modification. The effects of SG on the other endocrine cells of the pancreas, such as the alpha-cell population, and their regulatory mechanisms remain less studied.

Materials and methods: We focused our work on the changes in the alpha-cell population after SG in a healthy model of Wistar rats. We measured alpha-cell mass, glucose tolerance, and insulin release after oral glucose tolerance tests and plasma glucagon secretion patterns after insulin infusion. Three Wistar rat groups were employed: SG-operated, surgical control (Sham), and fasting control.

Results: The results obtained showed significant increases in the alpha-cell population after SG. The result was an increase in beta-cell transdifferentiation; it was shown by some expressed molecules (the loss of expression of Pdx-1 and the increase in Arx and Pax6 cells/mm2 of islet). The serum results were enhanced plasma glucagon secretion pattern after insulin infusion assays and normal glucose tolerance and insulin release after OGTT.

Conclusion: We concluded that SG leads to an expansion of the alpha-cell population, at expense of beta-cell; this expansion of alpha-cells is related to transdifferentiation. Plasma glucose level was not affected due to an increased glucagon response.

Keywords: Alpha-cells; Cellular differentiation; Glucagon; Incretins; Pancreas; Sleeve gastrectomy.

MeSH terms

  • Animals
  • Blood Glucose
  • Gastrectomy
  • Glucagon*
  • Glucagon-Like Peptide 1
  • Insulin
  • Jejunum
  • Obesity, Morbid* / surgery
  • Rats
  • Rats, Wistar

Substances

  • Blood Glucose
  • Insulin
  • Glucagon-Like Peptide 1
  • Glucagon